This webinar reviews the SARS-CoV-2 vaccines in development and how you can gain confidence in recommending them to your patients once authorized by the FDA. The speaker provides a brief history of vaccine development during past pandemics, discusses the development process for COVID-19 vaccines and addresses the differences between the vaccine candidates. You will also learn several tips for talking to patients about the potential new vaccines to overcome vaccine hesitancy.


01. Learning Objectives

  1. Describe the characteristics of the SARS-CoV-2 vaccine candidates including dosing schedule, storage and handling requirements, and effectiveness in preventing COVID-19.
  2. Compare the normal vaccine development process to the process of developing vaccines during a pandemic and how will this affect the future of vaccine development.
  3. Discuss different strategies for conversing with patients who are hesitant to receive a COVID-19 vaccine, once authorized.

04. Speaker(s)

John D. Grabenstein, RPh, PhD, PAPhA, FASHP

05. Speaker Disclosure Statement

John D. Grabenstein has served as a consultant for Valneva and has served on the advisory board for Janssen Vaccines, Bavarian Nordic, and VBI Vaccines in the last twelve months. The conflict of interest has been resolved by peer review of the slide content.

06. Acknowledgement of support

This program is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $199,847 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. government.

07. Pharmacist ACPE UAN#

0207-9999-20-215-H06-P

08. Pharmacy Technician ACPE UAN#

0207-9999-20-215-H06-T

09. Contact Hours

1.0

ACPE Statement

NCPA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program will provide 1.0 contact hour (0.1 CEU) of continuing pharmacy education credit. The participant will need to complete the components listed above including a pre-test, video(s), final assessment, and an activity evaluation. Each final assessment is considered complete with a grade of 70% or better. NCPA’s continuing pharmacy education policy provides you with two opportunities to successfully complete this continuing pharmacy education assessment. Please note that you will not be permitted to submit the assessment a third time.

Interest

  • Immunizations/Vaccines
  • COVID-19

Activities:Type
Creating Confidence in COVID-19 Vaccines
Creating Confidence in COVID-19 Vaccines - Pre-Test
eLearning Course
Creating Confidence in COVID-19 Vaccines - Video
eLearning Course
Creating Confidence in COVID-19 Vaccines Final Assessment
eLearning Course
Overview
Type:Learning Path
Credits:2
Credit Categories
Learning Time:1h  
Key Dates
Starts:12/08/2020
Enrollment:Prior to  12/02/2023
Enrollment